However, when ROS levels are decreased by Resveratrol administration, AP-1 composition shifts from Fra-1 to Fra-2-containing dimers, that limits the aggressiveness of MM cells [67]. The gene discussed is FOSL1; the disease is Miyoshi myopathy.